Inherited genetic mutations on chromosome 9 and subsequent enzymatic defects can explain the pathophysiology and causative mechanisms of FH in the LDL‐R, such as proprotein convertase subtilisin/Kexin type 9 (PCSK9) and apolipoprotein B8 (Figure 1). Here, PCSK9 is linked to familial hyperaldosteronism.